Prognosis of Japanese Patients With Coronary Artery Disease Who Underwent Implantable Cardioverter Defibrillator Implantation　― The JID-CAD Study ―-Reference-Cited by-同舟云学术

Prognosis of Japanese Patients With Coronary Artery Disease Who Underwent Implantable Cardioverter Defibrillator Implantation　― The JID-CAD Study ―

Published:2021-02-10 Issue:2 Volume:3 Page:69-76
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Kabutoya Tomoyuki¹,Mitsuhashi Takeshi²,Shimizu Akihiko³,Nitta Takashi⁴,Mitamura Hideo⁵,Kurita Takashi⁶,Abe Haruhiko⁷,Nakazato Yuji⁸,Sumitomo Naokata⁹,Kadota Kazushige¹⁰,Kimura Kazuo¹¹,Okumura Ken¹²

Affiliation:

1. Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University

2. Cardiology and Vascular Medicine, Hoshi General Hospital

3. Ube-Kohsan Central Hospital

4. Cardiovascular Surgery, Nippon Medical School

5. Cardiology, Tachikawa Hospital

6. Cardiology, Kindai University School of Medicine

7. Department of Heart Rhythm Management, University of Occupational and Environmental Health

8. Cardiology, Juntendo University Urayasu Hospital

9. Pediatric Cardiology, Saitama Medical University International Medical Center

10. Cardiology, Kurashiki Central Hospital

11. Division of Cardiology, Yokohama City University Medical Center

12. Division of Cardiology, Saiseikai Kumamoto Hospital

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/3/2/3_CR-20-0122/_pdf

Reference25 articles.

1. 1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–1940.

2. 2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883.

3. 3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–237.

4. 4. Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, Nishii N, et al. Current status of cardiac resynchronization therapy with defibrillators and factors influencing its prognosis in Japan. J Arrhythm 2013; 29: 168–174.

5. 5. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II registry. Heart 2009; 95: 216–220.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia;JACC: Asia;2023-06